Literature DB >> 15501541

Synthesis, anti-Trypanosoma cruzi activity and micelle interaction studies of bisguanylhydrazones analogous to pentamidine.

Márcia Narcizo Borges1, Jorge Cardoso Messeder, José Daniel Figueroa-Villar.   

Abstract

Three new bisguanylhydrazones analogous to pentamidine were synthesized, fully characterized and tested as anti-Trypanosoma cruzi candidates. Contrary to literature reports, that bicationic compounds are more active than monocationic compounds against Trypanosoma brucei, it was found that these bisguanylhydrazones are much less effective against T. cruzi than simple aromatic monoguanylhydrazones, thus suggesting different mechanism of action for both parasites. Spin-spin nuclear relaxation studies of the interaction of these compounds with SDS and CTAB micelles showed that only the most trypanocidal compound displays significant discrimination between anionic and cationic micelles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501541     DOI: 10.1016/j.ejmech.2004.07.001

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.

Authors:  Lucas N Alberca; María L Sbaraglini; Darío Balcazar; Laura Fraccaroli; Carolina Carrillo; Andrea Medeiros; Diego Benitez; Marcelo Comini; Alan Talevi
Journal:  J Comput Aided Mol Des       Date:  2016-02-18       Impact factor: 3.686

2.  Covalent attachment of the plant natural product naringenin to small glass and ceramic beads.

Authors:  Yuhua Lu; Niloufer G Irani; Erich Grotewold
Journal:  BMC Chem Biol       Date:  2005-10-10

3.  Synthesis of New Quinoline-Piperonal Hybrids as Potential Drugs against Alzheimer's Disease.

Authors:  Juliana de Oliveira C Brum; Denise Cristian F Neto; Joyce Sobreiro F D de Almeida; Josélia Alencar Lima; Kamil Kuca; Tanos Celmar C França; José D Figueroa-Villar
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.